Geode Capital Management
SER icon

Geode Capital Management’s Serina Therapeutics SER Stock Holding History

Geode Capital Management’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99K Sell
51,007
-13,966
-21% -$26.2K ﹤0.01% 4102
2026
Q1 		$126K Buy
64,973
+34,564
+114% +$76.1K ﹤0.01% 4069
2025
Q4 		$58.2K Buy
30,409
+801
+3% +$3.24K ﹤0.01% 4207
2025
Q3 		$159K Buy
29,608
+724
+3% +$3.85K ﹤0.01% 3997
2025
Q2 		$178K Sell
28,884
-322
-1% -$1.83K ﹤0.01% 3911
2025
Q1 		$166K Buy
29,206
+3,010
+11% +$14.2K ﹤0.01% 3899
2024
Q4 		$131K Buy
26,196
+2,170
+9% +$12.8K ﹤0.01% 4025
2024
Q3 		$161K Buy
24,026
+1,279
+6% +$10.2K ﹤0.01% 3979
2024
Q2 		$218K Buy
+22,747
New +$224K ﹤0.01% 3876
2024
Q1 		– Sell
-4,009
Closed -$54.3K – 4642
2023
Q4 		$54.3K Hold
4,009
– – ﹤0.01% 4327
2023
Q3 		$95.9K Buy
4,009
+1,229
+44% +$32.5K ﹤0.01% 4266
2023
Q2 		$87.3K Hold
2,780
– – ﹤0.01% 4377
2023
Q1 		$64.8K Sell
2,780
-52
-2% -$1.2K ﹤0.01% 4459
2022
Q4 		$54K Sell
2,832
-7
-0.2% -$148 ﹤0.01% 4575
2022
Q3 		$56K Hold
2,839
– – ﹤0.01% 4741
2022
Q2 		$57K Buy
2,839
+41
+1% +$1.11K ﹤0.01% 4749
2022
Q1 		$84K Hold
2,798
– – ﹤0.01% 4707
2021
Q4 		$107K Hold
2,798
– – ﹤0.01% 4710
2021
Q3 		$92K Hold
2,798
– – ﹤0.01% 4698
2021
Q2 		$152K Hold
2,798
– – ﹤0.01% 4441
2021
Q1 		$159K Hold
2,798
– – ﹤0.01% 4187
2020
Q4 		$149K Hold
2,798
– – ﹤0.01% 3969
2020
Q3 		$79K Hold
2,798
– – ﹤0.01% 3950
2020
Q2 		$93K Sell
2,798
-3,028
-52% -$89.2K ﹤0.01% 3871
2020
Q1 		$190K Buy
5,826
+155
+3% +$7.29K ﹤0.01% 3566
2019
Q4 		$363K Buy
5,671
+4
+0.1% +$216 ﹤0.01% 3608
2019
Q3 		$390K Buy
5,667
+164
+3% +$15.6K ﹤0.01% 3556
2019
Q2 		$710K Buy
5,503
+1,872
+52% +$253K ﹤0.01% 3336
2019
Q1 		$517K Buy
3,631
+147
+4% +$21.5K ﹤0.01% 3430
2018
Q4 		$366K Buy
+3,484
New +$443K ﹤0.01% 3479

Other funds holding SER

SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WA
Waverly Advisors Birmingham, Alabama $17.2B AUM 24.89% 1-Year Est. Return
KP
Keel Point Huntsville, Alabama $1.69B AUM 20.79% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Geode Capital Management's SER Position: Q2 2026 in Review

Geode Capital Management reduced its Serina Therapeutics (SER) stake by 21% in Q2 2026, selling an estimated $26.2K and leaving 51,007 shares worth $99K. The position accounts for ﹤0.01% of the portfolio, ranked #4102.

Geode Capital Management first reported a position in SER in Q4 2018 and has held it in 30 quarters since. The position peaked at $710K in Q2 2019. 27 funds tracked by Wall St. Rank hold SER as of Q2 2026.

  • Geode Capital Management held 51,007 shares of Serina Therapeutics worth $99K as of Q2 2026.
  • Geode Capital Management sold 13,966 Serina Therapeutics shares in Q2 2026, an estimated $26.2K.
  • Serina Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4102 holding.
  • Geode Capital Management first reported a position in Serina Therapeutics in Q4 2018 and has held it in 30 quarters since.
  • Geode Capital Management's Serina Therapeutics position peaked at $710K in Q2 2019.
  • 27 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.